Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

CohBar, NIAID to assess CB5064 Analogs for Covid-19 treatment

pharmaceutical-technologyJanuary 13, 2021

Tag: CohBar , NIAID , COVID-19 , CB5064

PharmaSources Customer Service